The Tel Aviv Stock Exchange (TASE) fell today. The Tel Aviv 25 Index fell 1.03% to 1,328.21 points, the Tel Aviv 100 Index fell 1.18% to 1,222.50 points, and the BlueTech 50 Index fell 1.69% to 356.27 points. Turnover was NIS 1.3 billion.
The TASE fell hard today, despite a mixed session on European markets. Wall Street is closed for Martin Luther King Day.
In the foreign currency market, the Bank of Israel set the shekel-dollar representative exchange rate at NIS 3.493/$, up 0.12% on Friday's rate, and shekel-euro representative exchange rate at NIS 4.731/€, down 0.28%.
In the bond market, long-term Shahar unlinked shekel government bonds and long term Galil CPI-linked government bonds fell. The corporate bond benchmark Tel-Bond 20 Index fell 0.15%.
In the stock market, Israel Chemicals Ltd. (TASE: ICL) fell 1.9%, and parent company Israel Corporation (TASE: ILCO) fell 1.6%, after Russian potash producer Uralkali JSC (LSE: URKA) announced a contract for the sale of 700,000 tons of potash at $305 per ton to a Chinese customer.
Bezeq Israeli Telecommunication Co. Ltd. (TASE: BEZQ) fell 3%, for the biggest loss among Tel Aviv 25 shares, and on the day's biggest turnover of NIS 73.1 million.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA), Israel Discount Bank (TASE: DSCT), and Partner Communications Ltd. (Nasdaq: PTNR; TASE: PTNR) were the only Tel Aviv 25 shares to buck the market, and barely. Teva rose 0.4% and Discount Bank and Partner both rose 0.3%.
Elsewhere in the market, Africa-Israel Investments Ltd. (TASE:AFIL) rose 2.6%, after announcing a new bond buyback, Cyren Ltd. (Nasdaq: CTCH; TASE: CTCH) (formerly Commtouch), rose 2.3% on a Chinese deal, and Pluristem Therapeutics Ltd. (Nasdaq:PSTI; TASE: PLTR) fell 15.4%, ahead of tomorrow's announcement of the results of a clinical trial.
Published by Globes [online], Israel business news - www.globes-online.com - on January 20, 2014
© Copyright of Globes Publisher Itonut (1983) Ltd. 2014